Facial soft-tissue fillers conference: Assessing the state of the science

Plastic and Reconstructive Surgery

Volumn 127, Issue SUPPL. 4 S, 2011, Pages

  Rohrich, Rod J ^a,b   Hanke, C William ^a,b   Busso, Mariano ^a,b   Carruthers, Alastair ^a,b   Carruthers, Jean ^a,b   Fagien, Steven ^a,b   Fitzgerald, Rebecca ^a,b   Glogau, Richard ^a,b   Greenberger, Phyllis E ^a,b   Lorenc, Z Paul ^a,b   Marmur, Ellen S ^a,b   Monheit, Gary D ^a,b   Pusic, Andrea ^a,b   Rubin, Mark G ^a,b   Rzany, Berthold ^a,b   Sclafani, Anthony ^a,b   Taylor, Susan ^a,b   Weinkle, Susan ^a,b   McGuire, Michael F ^a,b   Pariser, David M ^a,b   Casas, Laurie A ^a,b   Collishaw, Karen J ^a,b   Dailey, Roger A ^a,b   Duffy, Stephen C ^a,b   Edgar, Elizabeth Jan ^a,b   Greenan, Barbara L ^a,b   Haenlein, Kelly ^a,b   Henrichs, Ronald A ^a,b   Hume, Keith M ^a,b   Lum, Flora ^a,b   Nielsen, David R ^a,b   Poulsen, Lisle ^a,b   Schoaf, Lori ^a,b   Seward, William ^a,b   Begolka, Wendy Smith ^a,b   Stanton, Robert G ^a,b   Svedman, Katherine J ^a,b   Thomas, J Regan ^a,b   Sykes, Jonathan M ^a,b   Wargo, Carol ^a,b   Weiss, Robert A ^a,b   more..

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Laser and Skin Surgery Center of Indiana   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGY; ESTHETIC SURGERY; EVIDENCE BASED MEDICINE; FACE; HUMAN; SCIENCE; SURGERY;

COSMETIC TECHNIQUES; DERMATOLOGY; EVIDENCE-BASED MEDICINE; FACE; HUMANS; SCIENCE;

EID: 79955019821     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31820578d0     Document Type: Conference Paper

References (52)

1. U. S. Department of Health and Human Services, U. S. Food and Drug Administration. Panel Meeting Summary: November 18-19, 2008 Meeting of the General and Plastic Surgery Devices Panel. Available at: http://www.fda.gov/ cdrh/panel/summary/gpsd-111808.html. Accessed March 22, 2009.
2. Agency for Healthcare Research and Quality. Methods Reference Guide for Effectiveness and Comparative Effectiveness Reviews, Version 1.0 (draft posted October of 2007). Available at: http://effectivehealthcare.ahrq.gov/repFiles/ 2007-10DraftMethodsGuide.pdf. Accessed 2009.
3. Baumann LS, Shamban AT, Lupo MP, et al. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: A multicenter, double-masked, randomized, within-subject study. Dermatol Surg. 2007;33(Suppl 2): S128-S135. (Pubitemid 350233450)
4. Lupo MP, Smith SR, Thomas JA, Murphy DK, Beddingfield FC III. Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg. 2008;121:289-297.
5. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588-595. (Pubitemid 36702442)
6. Narins RS, Brandt FS, Lorenc ZP, et al. A randomized, multicenter study of the safety and efficacy of Dermicol-P35 and non-animal-stabilized hyaluronic acid gel for the correction of nasolabial folds. Dermatol Surg. 2007;33(Suppl 2): S213-S221. (Pubitemid 350233466)
7. Moers-Carpi M, Vogt S, Santos BM, Planas J, Vallve SR, Howell DJ. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg. 2007;33(Suppl 2): S144-S151. (Pubitemid 350233453)
8. Moers-Carpi MM, Tufet JO. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: A 12-month, multicenter, prospective, randomized, controlled, split-face trial. Dermatol Surg. 2008;34:210-215.
9. Carruthers A, Carey W, De Lorenzi C, Remington K, Schachter D, Sapra S. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, restylane perlane and hylaform, in the treatment of nasolabial folds. Dermatol Surg. 2005;31:1591-1598.
10. Onesti M, Toscani M, Curinga G, Chiummariello S, Scuderi N. Assessment of a new hyaluronic acid filler: Double-blind, randomized, comparative study between Puragen and Captique in the treatment of nasolabial folds. In Vivo 2009;23:479-486.
11. Denton AB, Tsaparas Y. Injectable hyaluronic acid for the correction of HIV-associated facial lipoatrophy. Otolaryngol Head Neck Surg. 2007;136:563-567. (Pubitemid 46517772)
12. Glogau RG, Kane MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg. 2008;34(Suppl 1): S105-S109.
13. Kono T, Kinney BM, Groff WF, Chan HH, Ercocen AR, Nozaki M. Randomized, evaluator-blind, split-face comparison study of single cross-linked versus double cross-linked hyaluronic acid in the treatment of glabellar lines. Dermatol Surg. 2008;34(Suppl 1): S25-S30. (Pubitemid 351792845)
14. Man J, Rao J, Goldman M. A double-blind, comparative study of nonanimal-stabilized hyaluronic acid versus human collagen for tissue augmentation of the dorsal hands. Dermatol Surg. 2008;34:1026-1031.
15. Carruthers J, Klein AW, Carruthers A, Glogau RG, Canfield D. Safety and efficacy of nonanimal stabilized hyaluronic acid for improvement of mouth corners. Dermatol Surg. 2005;31:276-280. (Pubitemid 43072978)
16. DeLorenzi C, Weinberg M, Solish N, Swift A. The long-term efficacy and safety of a subcutaneously injected large-particle stabilized hyaluronic acid-based gel of nonanimal origin in esthetic facial contouring. Dermatol Surg. 2009;35(Suppl 1):313-321.
17. Distante F, Pagani V, Bonfigli A. Stabilized hyaluronic acid of non-animal origin for rejuvenating the skin of the upper arm. Dermatol Surg. 2009;35(Suppl 1):389-393; discussion 394.
18. Cohen SR, Holmes RE. Artecoll: A long-lasting injectable wrinkle filler material. Report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg. 2004;114:964-976; discussion 977-979. (Pubitemid 40362114)
19. Cohen SR, Berner CF, Busso M, et al. ArteFill: A long-lasting injectable wrinkle filler material. Summary of the U. S. Food and Drug Administration trials and a progress report on 4-to 5-year outcomes. Plast Reconstr Surg. 2006;118(3 Suppl): 64S-76S. (Pubitemid 44319092)
20. Cohen SR, Berner CF, Busso M, et al. Five-year safety and efficacy of a novel polymethylmethacrylate aesthetic soft tissue filler for the correction of nasolabial folds. Dermatol Surg. 2007;33(Suppl 2): S222-S230. (Pubitemid 350233468)
21. Smith S, Busso M, McClaren M, Bass LS. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatol Surg. 2007;33(Suppl 2): S112-S121. (Pubitemid 350233446)
22. Monstrey SJ, Pitaru S, Hamdi M, et al. A two-stage phase I trial of Evolence30 collagen for soft-tissue contour correction. Plast Reconstr Surg. 2007;120:303-311. (Pubitemid 46956067)
23. Sclafani AP, Romo T III, Jacono AA. Rejuvenation of the aging lip with an injectable acellular dermal graft (Cymetra). Arch Facial Plast Surg. 2002;4:252-257.
24. De Boulle BK, Swinberghe S, Engman M, Shoshani D. Lip augmentation and contour correction with a ribose crosslinked collagen dermal filler. J Drugs Dermatol. 2009;8(3 Suppl): 1-8.
25. Sclafani AP, Romo T III, Jacono AA, McCormick SA, Cocker R, Parker A. Evaluation of acellular dermal graft (AlloDerm) sheet for soft tissue augmentation: A 1-year follow-up of clinical observations and histological findings. Arch Facial Plast Surg. 2001;3:101-103.
26. Sclafani AP, Romo T III, Parker A, McCormick SA, Cocker R, Jacono A. Autologous collagen dispersion (autologen) as a dermal filler: Clinical observations and histologic findings. Arch Facial Plast Surg. 2000;2:48-52.
27. Sclafani AP, Romo T III, Parker A, McCormick SA, Cocker R, Jacono A. Homologous collagen dispersion (dermalogen) as a dermal filler: Persistence and histology compared with bovine collagen. Ann Plast Surg. 2002;49:181-188. (Pubitemid 34848083)
28. Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg. 2008;34(Suppl 1): S9-S15. (Pubitemid 351792842)
29. Marmur ES, Taylor SC, Grimes PE, Boyd CM, Porter JP, Yoo JY. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI. Dermatol Surg. 2009;35(Suppl 2):1641-1645.
30. Carruthers A, Liebeskind M, Carruthers J, Forster BB. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds. Dermatol Surg. 2008;34(Suppl 1): S78-S84. (Pubitemid 351792854)
31. Silvers SL, Eviatar JA, Echavez MI, Pappas AL. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: One-year durability. Plast Reconstr Surg. 2006;118(3 Suppl): 34S-45S. (Pubitemid 44319089)
32. Beer K, Yohn M, Cohen JL. Evaluation of injectable CaHA for the treatment of mid-face volume loss. J Drugs Dermatol. 2008;7:359-366.
33. El-Beyrouty C, Huang V, Darnold CJ, Clay PG. Poly-L-lactic acid for facial lipoatrophy in HIV. Ann Pharmacother. 2006;40:1602-1606. (Pubitemid 44330204)
34. Moyle GJ, Brown S, Lysakova L, Barton SE. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med. 2006;7:181-185. (Pubitemid 43337597)
35. Lowe NJ, Maxwell CA, Lowe P, Shah A, Patnaik R. Injectable poly-l-lactic acid: 3 years of aesthetic experience. Dermatol Surg. 2009;35(Suppl 1):344-349.
36. Salles AG, Lotierzo PH, Gimenez R, Camargo CP, Ferreira MC. Evaluation of the poly-L-lactic acid implant for treatment of the nasolabial fold: 3-year follow-up evaluation. Aesthetic Plast Surg. 2008;32:753-756.
37. Negredo E, Higueras C, Adell X, et al. Reconstructive treatment for antiretroviral-associated facial lipoatrophy: A prospective study comparing autologous fat and synthetic substances. AIDS Patient Care STDS. 2006;20:829-837. (Pubitemid 46106070)
38. Beer K. A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella. Dermatol Surg. 2007;33(Suppl 2): S159-S167. (Pubitemid 350233455)
39. Sadick NS, Anderson D, Werschler WP. Addressing volume loss in hand rejuvenation: A report of clinical experience. J Cosmet Laser Ther. 2008;10:237-241.
40. Centers for Disease Control and Prevention. Acute renal failure associated with cosmetic soft-tissue filler injections: North Carolina, 2007. MMWR Morb Mortal Wkly Rep. 2008;57: p453-456.
41. Salles AG, Lotierzo PH, Gemperli R, et al. Complications after polymethylmethacrylate injections: Report of 32 cases. Plast Reconstr Surg. 2008;121:1811-1820. (Pubitemid 351642742)
42. Mirsaidi N. Post-Market Evaluation of Adverse Events Reported to FDA on Dermal Fillers. Washington, DC: U. S. Food and Drug Administration; 2009.
43. Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002;28:491-494. (Pubitemid 34686633)
44. Rossner F, Rossner M, Hartmann V, Erdmann R, Wiest LG, Rzany B. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: 8-year results from the Injectable Filler Safety study. J Cosmet Dermatol. 2009;8:14-18.
45. Rossner M, Rossner F, Bachmann F, Wiest L, Rzany B. Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid. Dermatol Surg. 2009;35(Suppl 1):367-374.
46. Grimes PE, Thomas JA, Murphy DK. Safety and effectiveness of hyaluronic acid fillers in skin of color. J Cosmet Dermatol. 2009;8:162-168.
47. Odunze M, Cohn A, Few JW. Restylane and people of color. Plast Reconstr Surg. 2007;120:2011-2016. (Pubitemid 350306701)
48. Kosowski TR, McCarthy C, Reavey PL, et al. A systematic review of patient-reported outcome measures after facial cosmetic surgery and/or nonsurgical facial rejuvenation. Plast Reconstr Surg. 2009;123:1819-1827.
49. Mest DR, Humble G. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: The US experience. Dermatol Surg. 2006;32:1336-1345. (Pubitemid 44691136)
50. Judodihardjo H, Dykes P. Objective and subjective measurements of cutaneous inflammation after a novel hyaluronic acid injection. Dermatol Surg. 2008;34(Suppl 1): S110-S114. (Pubitemid 351792860)
51. Hamilton RG, Strobos J, Adkinson NF Jr. Immunogenicity studies of cosmetically administered nonanimal-stabilized hyaluronic acid particles. Dermatol Surg. 2007;33(Suppl 2): S176-S185. (Pubitemid 350233457)
52. Shoshani D, Markovitz E, Cohen, Heremans A, Goldlust A. Skin test hypersensitivity study of a cross-linked, porcine collagen implant for aesthetic surgery. Dermatol Surg. 2007;33(Suppl 2): S152-S158. (Pubitemid 350233454)